HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ryusaburo Mori Selected Research
Ryusaburo Mori Research Topics
Disease
21
Macular Degeneration (Age-Related Maculopathy)
03/2024 - 10/2002
19
Polypoidal Choroidal Vasculopathy
02/2024 - 05/2004
7
Hemorrhage
04/2022 - 07/2008
7
Retinal Detachment (Retinal Detachments)
02/2022 - 10/2011
5
Diabetic Retinopathy (Retinopathy, Diabetic)
04/2022 - 05/2010
5
Endophthalmitis (Ophthalmia)
02/2022 - 12/2008
4
Central Serous Chorioretinopathy
01/2021 - 10/2011
3
Inflammation (Inflammations)
11/2023 - 06/2020
3
Epiretinal Membrane (Epiretinal Membranes)
08/2019 - 07/2009
3
Choroidal Neovascularization
07/2008 - 10/2002
2
Retinal Vein Occlusion
01/2023 - 04/2009
1
Retinal Vasculitis
11/2023
1
Atherosclerosis
01/2023
1
Iritis
07/2022
1
Choroidal Effusions
02/2022
1
COVID-19
02/2022
1
Infections
02/2022
1
Retinal Drusen
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Vitreous Hemorrhage
09/2021
1
Fatigue
11/2020
1
Melanoma (Melanoma, Malignant)
06/2020
1
Neoplasms (Cancer)
06/2020
1
Vision Disorders (Hemeralopia)
06/2020
1
Vitreous Detachment (Posterior Vitreous Detachment)
10/2019
1
Cataract (Cataracts)
10/2017
1
Wounds and Injuries (Trauma)
10/2017
1
Retinal Perforations
06/2010
1
Rupture
08/2009
1
Macular Edema
04/2009
1
Hypoxia (Hypoxemia)
11/2008
Drug/Important Bio-Agent (IBA)
14
Retinaldehyde (Retinal)
IBA
11/2023 - 04/2009
8
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
02/2024 - 07/2007
8
Indocyanine Green (Cardio-Green)
FDA Link
Generic
01/2017 - 10/2002
7
Ranibizumab (Lucentis)
FDA Link
02/2024 - 07/2013
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2022 - 11/2008
5
faricimab
IBA
03/2024 - 01/2023
4
brolucizumab
IBA
11/2023 - 01/2021
4
aflibercept
IBA
09/2023 - 01/2017
3
Povidone-Iodine (Betadine)
FDA Link
Generic
02/2022 - 08/2013
2
Tissue Plasminogen Activator (Alteplase)
FDA Link
04/2022 - 01/2016
2
N-acetyltryptophanamide (NATA)
IBA
01/2020 - 01/2017
2
Capsules (Microcapsules)
IBA
10/2019 - 08/2009
2
Verteporfin (Visudyne)
FDA Link
10/2011 - 07/2007
2
Bevacizumab (Avastin)
FDA Link
05/2010 - 03/2008
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2023
1
pro-brain natriuretic peptide (1-76)
IBA
01/2023
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
07/2022
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
02/2022
1
7,14-dihydroxypregn-4-ene-3,20-dione
IBA
04/2021
1
Steroids
IBA
11/2020
1
Monoclonal Antibodies
IBA
06/2020
1
Retinal Pigments (Pigments, Visual)
IBA
06/2020
1
Nivolumab
IBA
06/2020
1
Immune Checkpoint Inhibitors
IBA
06/2020
1
Programmed Cell Death 1 Receptor
IBA
06/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
09/2019
1
Lutein
IBA
01/2017
1
Antioxidants
IBA
01/2017
1
Complement Factor B (Factor B)
IBA
06/2014
1
Complement C2 (Complement Component 2)
IBA
06/2014
1
Complement Factor H (Factor H)
IBA
09/2011
1
perflutren (octafluoropropane)
FDA Link
06/2010
1
coomassie Brilliant Blue
IBA
07/2009
1
Triamcinolone Acetonide (Azmacort)
FDA Link
Generic
04/2009
1
Fluorescein (Funduscein)
FDA Link
Generic
07/2008
Therapy/Procedure
10
Photochemotherapy (Photodynamic Therapy)
02/2024 - 07/2007
10
Vitrectomy
10/2019 - 12/2008
8
Intravitreal Injections
11/2023 - 08/2013
5
Injections
09/2023 - 08/2013
5
Therapeutics
01/2023 - 05/2010
4
Aftercare (After-Treatment)
04/2022 - 05/2008
2
Ambulatory Surgical Procedures (Outpatient Surgery)
09/2019 - 10/2017
1
Transplantation
10/2019
1
Retreatment
06/2018
1
Sutures (Suture)
10/2017
1
Cannula
06/2010
1
Anesthesia
08/2009
1
Phacoemulsification
08/2009
1
Light Coagulation
10/2002
1
Lasers (Laser)
10/2002